Modeling bioavailability to organs protected by biological barriers.

about

Different expression of β subunits of the KCa1.1 channel by invasive and non-invasive human fibroblast-like synoviocytes Computational pharmacokinetics at a crossroads.

P2860

Q36890498-A6ACA82F-9091-482A-A60A-C1841C611891 Q39495616-D86D366D-BEA6-460E-98E3-0713BF8C767A

P2860

Modeling bioavailability to organs protected by biological barriers.

Item

http://www.wikidata.org/entity/Q38288015

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Modeling bioavailability to organs protected by biological barriers.

@en

type

Item

label

Modeling bioavailability to organs protected by biological barriers.

@en

prefLabel

Modeling bioavailability to organs protected by biological barriers.

@en

P1476

Modeling bioavailability to organs protected by biological barriers.

@en

P2093

Nadia Quignot

http://www.w3.org/2001/XMLSchema#string

P2860

Brain endothelial cell-cell junctions: how to "open" the blood brain barrier

The Simcyp population-based ADME simulator

Pharmacokinetics explain in vivo/in vitro discrepancies of carcinogen-induced gene expression alterations in rat liver and cultivated hepatocytes

Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport.

From physicochemistry to absorption and distribution: predictive mechanistic modelling and computational tools.

Modeling gastrointestinal drug absorption requires more in vivo biopharmaceutical data: experience from in vivo dissolution and permeability studies in humans.

QSAR models for predicting the similarity in binding profiles for pairs of protein kinases and the variation of models between experimental data sets.

Regulation of mucosal structure and barrier function in rat colon exposed to tumor necrosis factor alpha and interferon gamma in vitro: a novel model for studying the pathomechanisms of inflammatory bowel disease cytokines.

Application of quantitative structure-activity relationships for modeling drug and chemical transport across the human placenta barrier: a multivariate data analysis approach.

Silver nanoparticle induced blood-brain barrier inflammation and increased permeability in primary rat brain microvessel endothelial cells.

P2888

2193-9616-1-8

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/2193-9616-1-8

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Nadia Quignot

P577

2013-05-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

237090037

http://www.w3.org/2001/XMLSchema#string

P6179

1013366491

http://www.w3.org/2001/XMLSchema#string

P698

25505653

http://www.w3.org/2001/XMLSchema#string

P932

4230447

http://www.w3.org/2001/XMLSchema#string

Modeling bioavailability to organs protected by biological barriers.

about

P2860

P2860

Modeling bioavailability to organs protected by biological barriers.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P50

P577

P5875

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P50

P577

P5875

P6179

P698

P932